Transplant Diagnostics Market Size, Company Profiles and Business Trends by 2028
Market Overview:
According to a new market research study titled ‘Transplant Diagnostics Market to 2027 – Global Analysis and Forecasts by Product & Services, Type, Technology, Application, and End User’. The global transplant diagnostics market is expected to reach US$ 1,542.89 Mn in 2027 from US$ 789.88 Mn in 2018. The market is estimated to grow with a CAGR of 7.9% from 2019-2027. The report highlights the trends prevalent in the global transplant diagnostics market and the factors driving the market along with those that act as deterrents to its growth.
Get Sample PDF: https://www.theinsightpartners.com/sample/TIPRE00003076/
Transplant diagnostics refers to the diagnostics tests that are conducted on the organs that are meant to be transplanted. These tests are either conducted pre transplantation as well as post transplantation. Some of the common techniques used in transplant diagnostics include, sequence based molecular assays, PCR based molecular assays and also non-molecular assays in certain cases. Transplant diagnostics is an essential factor in organ transplantation as it avoids any further complications that could occur after a transplant procedures
Global transplant diagnostics market, based on application was segmented as, diagnostic applications and research applications. In 2018, diagnostic applications segment held the largest share of the market, by application. Moreover, the segment is expected to grow at the fastest rate during the coming years owing to the prevalence of infectious as well as chronic diseases, leading to the demand for an organ transplant.
The major players operating in the transplant diagnostics market are, Thermo Fisher Scientific Inc., Abbott, Illumina, Inc., F. Hoffmann-La Roche Ltd, Bio-Rad Laboratories, Inc., bioMérieux SA, QIAGEN, Hologic Inc., Luminex Corporation, and Omixon Inc. Inorganic activities such as, partnership is a prominent parameter undertaken by industry players. For instance, in May, 2018, Omixon entered into a partnership with Dilen s.r.o. As part of the partnership, Dilen has been appointed as the exclusive distributor in Kazakhstan. The developments performed by the companies are helping the market to grow in the coming years.
Buy Now: https://www.theinsightpartners.com/buy/TIPRE00003076/
The report segments the global transplant diagnostics market as follows:
Global Transplant Diagnostics Market – By Product & Services
Instruments
Reagents & Consumables
Software & Services
· Global Transplant Diagnostics Market – By Type
Solid Organ Transplantation
Lung Transplantation
Liver Transplantation
Kidney Transplantation
Heart Transplantation
Other Solid Organ Transplantations
Soft Tissue Transplantation
Stem Cell Transplantation
Global Transplant Diagnostics Market – By Technology
Molecular Assays
Sequencing-Based Molecular Assays
Next-Generation Sequencing
Sanger Sequencing
Other Sequencing-Based Molecular Assays
PCR-Based Molecular Assays
Real-Time PCR
Sequence-Specific Primer-PCR
Other PCR-Based Molecular Assays
Non-Molecular Assays
· Global Transplant Diagnostics Market – By Application
Diagnostic Applications
Pre-Transplantation Diagnostics
Post-Transplantation Diagnostics
Research Applications
· Global Transplant Diagnostics Market – By End User
Hospitals & Transplant Centers
Research Laboratories & Academic Institutes
Independent Reference Laboratories
· Global Transplant Diagnostics Market – By Geography
North America
S.
Canada
Mexico
Europe
France
Germany
K
Spain
Italy
Asia Pacific (APAC)
China
India
Japan
Australia
South Korea
Middle East & Africa (MEA)
Saudi Arabia
A.E
South Africa
South & Central America (SCAM)
Brazil
Argentina
Contact Us:
If you have any queries about this report or if you would like further information, please contact us:
Contact Person: Sameer Joshi
E-mail: sales@theinsightpartners.com
Phone: +1-646-491-9876
